Eric Dube
Vorstandsvorsitzender bei TRAVERE THERAPEUTICS, INC.
Vermögen: 810 531 $ am 31.05.2024
Profil
Eric M.
Dube is currently the President, Chief Executive Officer & Director at Travere Therapeutics, Inc. He is also a Director at the Biotechnology Innovation Organization and an Independent Director at Reneo Pharmaceuticals, Inc. Previously, he held positions as a Director at BIOCOM, SVP & Head-Global Respiratory Franchise at GSK Plc, President & Head-North America at ViiV Healthcare Ltd., and Senior VP & Head-Global Respiratory Franchise at GlaxoSmithKline KK.
He has also served as a Trustee at Aids United.
Dr. Dube obtained his graduate and doctorate degrees from Cornell University and his undergraduate degree from Santa Clara University in 1994.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 109 236 ( 0,14% ) | 810 531 $ | 31.05.2024 | |
| 15.03.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Eric Dube
| Unternehmen | Position | Beginn |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Vorstandsvorsitzender | 04.01.2019 |
| RENEO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.03.2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Eric Dube
| Unternehmen | Position | Ende |
|---|---|---|
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Präsident | 01.12.2018 |
| GSK PLC | Corporate Officer/Principal | 01.12.2017 |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Corporate Officer/Principal | 01.12.2017 |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
| Aids United | Direktor/Vorstandsmitglied | - |
Ausbildung von Eric Dube
| Santa Clara University | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GSK PLC | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
| Aids United | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
GlaxoSmithKline KK
GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Consumer Non-Durables |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
